Intrexon Corp (XON) 26.21 $XON Fibrocell to Present at

New Post Public Reply Private Reply Replies (0) Message Board

Jul 12, 2016 at 2:14 PM

Intrexon Corp (XON) 26.21 $XON

Fibrocell to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
GlobeNewswire - Thu Jul 07, 3:05PM CDT
Fibrocell Science, Inc., (NASDAQ:FCSC) today announced that David Pernock, Chairman and Chief Executive Officer of Fibrocell, will present at Cantor Fitzgerald's 2 Annual Healthcare Conference at 1:30 pm ET on Wednesday, July 13 in New York City. Prior to his presentation, Mr. Pernock will participate in a panel discussion on gene therapy at 12:15 pm ET.
FCSC: 1.19 (+0.01), XON: 26.21 (-0.02)

7-Day Deadline Alert: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Intrexon Corporation and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Sat Jul 02, 11:52AM CDT
IRVINE, CA / ACCESSWIRE / July 2, 2016 / Khang & Khang LLP (the "Firm"

announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company"

(NYSE: XON). Investors who purchased or otherwise acquired shares between May 12, 2015 and April 20, 2016, inclusive (the "Class Period"

, are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline.
XON: 26.21 (-0.02)

INTREXON 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Intrexon Corporation - XON
GlobeNewswire - Fri Jul 01, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF"

and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until July 5, 2016 to file lead plaintiff applications in a securities class action lawsuit against Intrexon Corporation (NYSE:XON). Investor losses must relate to purchases of the Company's securities between May 12, 2015 and April 20, 2016. This action is pending in the United States District Court for the Northern District of California.
XON: 26.21 (-0.02)

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intrexon Corporation of Class Action Lawsuit and Upcoming Deadline - XON
ACCESSWIRE - Fri Jul 01, 5:13PM CDT
NEW YORK, NY / July 1, 2016 / ACCESSWIRE / Pomerantz LLP announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company"

(NYSE: XON) and certain of its officers. The class action, filed in United States District Court, Northern District of California, and docketed under 16-cv-02457, is on behalf of a class consisting of all persons or entities who purchased Intrexon securities between May 12, 2015 and April 20, 2016 inclusive (the "Class Period"

. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act"

.
XON: 26.21 (-0.02)

DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Intrexon Corporation (XON) and Lead Plaintiff Deadline of July 5, 2016
ACCESSWIRE - Wed Jun 29, 8:29AM CDT
NEW YORK, NY / ACCESSWIRE / June 29, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against Intrexon Corporation ("Intrexon" or "the Company"

(NYSE: XON). The class action has been filed on behalf of a class consisting of all persons or entities who purchased Horsehead securities between May 12, 2014 and April 20, 2016, both dates inclusive (the "Class Period"

.
XON: 26.21 (-0.02)

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Intrexon Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 5, 2016 - XON
PR Newswire - Tue Jun 28, 8:51AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
XON: 26.21 (-0.02)

ZIOPHARM Completes Enrollment in Second Patient Cohort and Initiates Enrollment in Third Cohort in Phase 1 Study of Gene Therapy Candidate Ad-RTS-hIL-12 in Brain Cancer
GlobeNewswire - Mon Jun 27, 3:05PM CDT
ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on new cancer immunotherapies, today announced the successful completion of enrollment in the first and second dosing cohorts as well as the initiation of enrollment in a third cohort in the Company's ongoing multi-center Phase 1 study of Ad-RTS-hIL-12 + orally administered veledimex to treat recurrent or progressive glioblastoma (GBM) or grade III malignant glioma. Ad-RTS-hIL-12 + veledimex is a novel viral gene therapy candidate for the controlled expression of interleukin 12 (IL-12), a critical protein for stimulating an anti-cancer immune response.
ZIOP: 5.99 (+0.06), XON: 26.21 (-0.02)

FINAL DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit Against Intrexon Corporation And Reminds Shareholders With Losses In Excess of $100,000 To Contact The Firm
ACCESSWIRE - Mon Jun 27, 2:42PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 27, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company"

(NYSE: XON) concerning possible violations of federal securities laws between May 12, 2015 and April 20, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 5, 2016, lead plaintiff motion deadline.
XON: 26.21 (-0.02)

INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Intrexon Corporation and a Lead Plaintiff Deadline of July 5, 2016 - XON
GlobeNewswire - Fri Jun 24, 11:18AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors who purchased Intrexon Corporation ("Intrexon"

(NYSE:XON) securities between May 12, 2015 and April 20, 2016.
XON: 26.21 (-0.02)

FINAL NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Intrexon Corporation and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jun 24, 11:13AM CDT
IRVINE, CA / ACCESSWIRE / June 24, 2016 / Khang & Khang LLP (the "Firm"

announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company"

(NYSE: XON). Investors who purchased or otherwise acquired shares between May 12, 2015 and April 20, 2016, inclusive (the "Class Period"

, are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline.
XON: 26.21 (-0.02)

INTREXON DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Intrexon Corporation And Reminds Shareholders With Losses In Excess of $100,000 To Contact The Firm
ACCESSWIRE - Thu Jun 23, 5:44PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 23, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company"

announces that a class action lawsuit has been filed on behalf of investors who purchased Intrexon Corporation ("Intrexon" or the "Company"

(NYSE: XON) securities between May 12, 2015 and April 20, 2016, inclusive (the "Class Period"

. Intrexon investors have until July 5, 2016 to file a lead plaintiff motion.
XON: 26.21 (-0.02)

How These Biotech's Stocks are Performing? - Intrexon, Vertex Pharma, Arena Pharma, and Regeneron Pharma
PR Newswire - Thu Jun 23, 6:30AM CDT
The Biotechnology industry might still be in rough waters, but it continues to present great opportunities to investors. Stock-Callers.com assesses the recent performances of our featured companies for today: Intrexon Corp. (NYSE: XON), Vertex Pharmaceuticals Inc. (NASDAQ: VRTX), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN). Learn more about these stocks and receive your complimentary trade alerts at:
VRTX: 90.36 (+0.26), XON: 26.21 (-0.02), ARNA: 1.64 (+0.02), REGN: 371.00 (-4.74)

FINAL NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Intrexon Corporation And Advises Investors With Losses To Contact The Firm
ACCESSWIRE - Wed Jun 22, 5:52PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 22, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company"

(NYSE: XON) concerning possible violations of federal securities laws between May 12, 2015 and April 20, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 6, 2016, lead plaintiff motion deadline.
XON: 26.21 (-0.02)

Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Intrexon Corporation (XON) and Encourages Investors to Contact the Firm
BusinessWire - Wed Jun 22, 4:30PM CDT
Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all persons or entities who acquired Intrexon Corporation (NYSE:XON) securities between May 12, 2015 and April 20, 2016 (the "Class Period"

.
XON: 26.21 (-0.02)

Inovio Stock Up, Zika Vaccine Gets Nod for Phase I Study
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 3:51PM CDT
Inovio Pharmaceuticals (INO) and GeneOne Life Science will begin the first Zika vaccine study in human volunteers; Inovio's stock gains.
INO: 9.17 (+0.05), ANIP: 55.79 (+0.41), XON: 26.21 (-0.02), RTRX: 18.63 (+0.16)

INTREXON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Intrexon Corporation - XON
PR Newswire - Fri Jun 17, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF"

and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 5, 2016 to file lead plaintiff applications in a securities class action lawsuit against Intrexon Corporation (NYSE: XON), if they purchased the Company's securities between May 12, 2015 and April 20, 2016, inclusive (the "Class Period"

. This action is pending in the United States District Court for the Northern District of California.
XON: 26.21 (-0.02)

DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Intrexon Corporation (XON) and Lead Plaintiff Deadline: July 5, 2016
ACCESSWIRE - Fri Jun 17, 11:49AM CDT
NEW YORK / ACCESSWIRE / June 17, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against Intrexon Corporation ("Intrexon" or "the Company"

.
XON: 26.21 (-0.02)

Fibrocell Announces Initiation of Patient Recruitment in Phase I/II Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa
GlobeNewswire - Mon Jun 13, 7:07AM CDT
Fibrocell Science, Inc. (NASDAQ:FCSC), an autologous cell and gene therapy company translating personalized biologics into medical breakthroughs for diseases affecting the skin, connective tissue and joints, today announced the initiation of adult patient recruitment in its Phase I/II clinical trial of FCX-007 for the treatment of recessive dystrophic epidermolysis bullosa (RDEB).
FCSC: 1.19 (+0.01), XON: 26.21 (-0.02)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Charter Next Generation Unveils Gen 2 MDO-PE Films

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Cure Blindness Project's 770K Screenings for World Sight Day

Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...

Truss Financial Tackles Home Equity Closing Delays

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Cala Launches Game-Changer Wearable for Tremor Relief

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Epic Political Thriller Explores Humanity's Future

Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...

Pushing for National Liver Cancer Awareness in 2026

The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...

JiMMYBAR! Expands Creatine Market with Target Launch

JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...

Skandia's Soundproofing Kit Expands to Brazil's Skies

Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...

ROKFORM’s Signal Card: A Wallet Tracker for All

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Community Banks Missing $106B Lending Opportunity?

A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...